We’ve recently shared more recognition of BIOLIFE4D and our scientific innovation in the global media, as outlets like BBC showcased our life-saving technology. Today we’re pleased to announce that we were recently recognized as a nominee for the 17th Annual Chicago Innovation Awards, held each year to celebrate innovators within the Chicago-ecosystem.
BIOLIFE4D was nominated in the Health & Medicine category for the innovation behind the development of our 3D bioprinted cardiac patch, revealed earlier this summer. An industry-first, BIOLIFE4D successfully printed a cardiac patch containing multiple cell types of which the human heart is made of rather than just cardiomyocytes and included vascularization. This milestone was achieved in just a few days and much sooner than the 6-8 month timeline often referenced in scientific literature.
The nomination for the Annual Chicago Innovation Awards represents another achievement for our company as we see further development of our life-saving technology. To receive this recognition means people are taking notice of what we are accomplishing, and our mission is spreading.
The Chicago Innovation Awards have long been a positive platform for local startups and innovators to gain exposure and accelerate their businesses – the past 42 winners that have been acquired have combined for $85 billion in exits.
For more information on the 17th Annual Chicago Innovation Awards, please visit their website.
To learn more about BIOLIFE4D and to express interest in investing please watch this video or visit https://biolife4d.com/invest/.
The post BIOLIFE4D Nominated for 17th Annual Chicago Innovation Awards! appeared first on BIOLIFE4D.
